Lv612
2120 积分 2024-04-01 加入
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
17天前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
17天前
已完结
The pathogenesis of IgA nephropathy and implications for treatment
2个月前
已完结
O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy
3个月前
已完结
Novel, tightly structurally related N-myristoyltransferase inhibitors display equally potent yet distinct inhibitory mechanisms
3个月前
已完结
Protein degraders push into novel target space
4个月前
已完结
Molecular mechanism of IgE-mediated FcεRI activation
4个月前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
4个月前
已完结
The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development
4个月前
已完结
Therapeutic potential of cis-targeting bispecific antibodies
5个月前
已完结
皖公网安备34019202002308
